Lu-PSMA Radioligand Therapy for advanced Prostate Cancer

被引：0
|
作者：
Derlin, T. [1 ]
机构：
[1] Hannover Med Sch, Zentrum Radiol, Klin Nukl Med, Carl Neuberg Str 1, D-30625 Hannover, Germany
来源：
RADIOLOGE | 2017年 / 57卷 / 12期
关键词：
D O I：
10.1007/s00117-017-0283-2
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
[No abstract available]
引用
收藏
页码：1001 / 1003
页数：3
相关论文
共 50 条
  • [1] Hematotoxicity and Nephrotoxicity in Prostate Cancer Patients Undergoing Radioligand Therapy with [177Lu]Lu-PSMA I&T
    Hartrampf, Philipp E.
    Weinzierl, Franz-Xaver
    Serfling, Sebastian E.
    Pomper, Martin G.
    Rowe, Steven P.
    Higuchi, Takahiro
    Seitz, Anna Katharina
    Kuebler, Hubert
    Buck, Andreas K.
    Werner, Rudolf A.
    CANCERS, 2022, 14 (03)
  • [2] Lu-PSMA Therapy
    Parent, Ephraim E.
    Savir-Baruch, Bital
    Gayed, Isis W.
    Almaguel, Frankis
    Chin, Bennett B.
    Pantel, Austin R.
    Armstrong, Evan
    Morley, Amanda
    Ippisch, Robin C.
    Flavell, Robert R.
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2022, 50 (03) : 205 - 212
  • [3] Prostate Cancer Theranostics With 177 Lu-PSMA
    Ahmadzadehfar, Hojjat
    Seifert, Robert
    Afshar-Oromieh, Ali
    Kratochwil, Clemens
    Rahbar, Kambiz
    SEMINARS IN NUCLEAR MEDICINE, 2024, 54 (04) : 581 - 590
  • [4] 177Lu-PSMA Radioligand Therapy for Prostate Cancer
    Fendler, Wolfgang P.
    Rahbar, Kambiz
    Herrmann, Ken
    Kratochwil, Clemens
    Eiber, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (08) : 1196 - 1200
  • [5] Dual Radionuclide Therapy: The Synergistic Effects of [161Tb]Tb-PSMA and [177Lu]Lu-PSMA in Advanced Prostate Cancer Post [177Lu]Lu-PSMA Failure
    Abdlkadir, Ahmed Saad
    Abufara, Alaa
    Al-Ibraheem, Akram
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 58 (06) : 381 - 382
  • [6] PSMA radioligand therapy in patients with advanced prostate cancer
    Boegemann, M.
    Herrmann, K.
    Radtke, J. P.
    Rahbar, K.
    UROLOGE, 2020, 59 (06): : 680 - 686
  • [7] Radioligand Therapy of metastatic Prostate Cancer with Lu-PSMA-617
    Manych, Matthias
    AKTUELLE UROLOGIE, 2017, 48 (05)
  • [8] Analysing the Tumour Transcriptome of Prostate Cancer to Predict Efficacy of Lu-PSMA Therapy
    Handke, A.
    Kesch, C.
    Fendler, W.
    Telli, T.
    Liu, Y.
    Hakansson, A.
    Davicioni, E.
    Hughes, J.
    Song, H.
    Lueckerath, K.
    Herrmann, K.
    Hadaschik, B.
    Seifert, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S180 - S180
  • [9] Analysing the tumor transcriptome of prostate cancer to predict efficacy of Lu-PSMA therapy
    Handke, Analena
    Kesch, Claudia
    Fendler, Wolfgang Peter
    Telli, Tugce
    Liu, Yang
    Hakansson, Alexander
    Davicioni, Elai
    Hughes, Jason
    Song, Hong
    Lueckerath, Katharina
    Herrmann, Ken
    Hadaschik, Boris
    Seifert, Robert
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (10)
  • [10] EANM-EAU consensus on PSMA PET/CT in respect to radioligand therapy ([177Lu]Lu-PSMA)
    Fanti, Stefano
    Kunikowska, Jolanta
    Walz, Jochen
    Witjes, Wim
    Bjartell, Anders
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (10) : 3328 - 3329
12345